Isoquinoline-3-carboxylic acid hydrate

Catalog No.: 
ACMOHD054
CAS No.: 
203626-75-9
Molecular Formula: 
C10H9NO3
Molecular Weight: 
191.19
Isoquinoline-3-carboxylic acid hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$136.00In stockIn stock
100g95%$488.00In stockInquiry
500g95%$1776.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameIsoquinoline-3-carboxylic acid hydrate
IUPAC Nameisoquinoline-3-carboxylic acid hydrate
MDL No.MFCD00075137
Molecular FormulaC10H9NO3
Molecular Weight191.19
SMILESO=C(C1=CC2=C(C=N1)C=CC=C2)O.[H]O[H]
InChI KeyIXFLTVWYYQIVRB-UHFFFAOYSA-N
Synonym3-Isoquinolinecarboxylic acid hydrate, 99% | 3-Isoquinolinecarboxylic acid, hydrate | A814490 | 3-IsoquinolinecarboxylicAcidHydrate | isoquinoline 3-carboxylic acid hydrate | J-650284 | SCHEMBL1201320 | 3-Isoquinolinecarboxylic acid hydrate (1:1) | A81485
CAS No.203626-75-9
PubChem CID2736704

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMOHD054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSPC893 route compound structure diagram
    ACXSPC89327104-73-0In Stock
  2. Then
  3. ACMOHD054 route product structure diagram
    ACMOHD054203626-75-9In Stock
Inquiry

2. ACMOHD054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJENH584 route compound structure diagram
    ACJENH58450458-79-2In Stock
  2. Then
  3. ACMOHD054 route product structure diagram
    ACMOHD054203626-75-9In Stock
Inquiry

3. ACMOHD054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMOHD054 route product structure diagram
    ACMOHD054203626-75-9In Stock
Inquiry

Comments (0)